Observed arrival · 2026-10-18
Wellchosen Health's cash-pay care tracker
A US guide compares cash prices for GLP-1s, hormone therapy and other self-pay care, alongside reviews of providers and regulatory records.
- For
- US patients comparing self-pay care options
- Worth noticing
- Its stated review rule flags live FDA-cited claims, a BBB rating of D or F, patterned billing complaints, or regulator action as Avoid—and says it will not link those providers.
Field notes
The page breaks out categories including GLP-1 brands and doses, menopause therapy, TRT, concierge medicine, direct primary care, longevity testing and wellness injections. It says listed prices come from seller or drugmaker pages, with dates and exclusions noted; examples include $50–$100 monthly for direct primary care and $2,250–$2,930 annual MDVIP fees. Its stated review system separates providers into Clean, Use caution, Avoid and Not yet rated.
Observed signals
Read the marks
Editorial observations of this landing page, not a rating.
One card from the complete issue